ZWS (ZWS) investor files to sell 25,000 shares of common stock

Rhea-AI Filing Summary

A shareholder of ZWS filed a notice to sell up to 25,000 shares of common stock through Goldman Sachs & Co. LLC on the NYSE. The proposed sale has an aggregate market value of $1,329,500, based on the filer’s disclosure, and is scheduled for August 4, 2026.

The issuer reports that 165,864,097 shares of common stock are outstanding. The filing also lists prior acquisitions of common stock as compensation through Performance Awards, including 5,297 shares dated February 10, 2025 and 19,703 shares dated October 26, 2021, both from the issuer as compensation.

Key Figures

Shares to be sold: 25,000 shares Aggregate market value: $1,329,500 Shares outstanding: 165,864,097 shares +2 more

5 metrics

Shares to be sold 25,000 shares Common stock proposed for sale through Goldman Sachs & Co. LLC

Aggregate market value $1,329,500 Aggregate market value of the 25,000 shares of common stock

Shares outstanding 165,864,097 shares Common shares outstanding for the issuer

Performance Awards 2025 5,297 shares Common stock acquired as compensation on 02/10/2025

Performance Awards 2021 19,703 shares Common stock acquired as compensation on 10/26/2021

Key Terms

Performance Awards, aggregate market value, compensation

3 terms

Performance Awards financial

"Acquired as compensation -- Performance Awards | The Issuer"

aggregate market value financial

"25000 | 1329500 | 165864097 | 08/04/2026 | NYSE"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

compensation financial

"Acquired as compensation -- Performance Awards | The Issuer"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/04/2026 - 06:09 PM Accepted by SEC EDGAR 08/04/2026 - 06:09 PM Learn about SEC filing dates

FAQ

What stock sale is disclosed for ZWS in this Form 144 filing?

The filing discloses a proposed sale of 25,000 shares of ZWS common stock. The transaction is to be executed through Goldman Sachs & Co. LLC on the NYSE, with a disclosed aggregate market value of $1,329,500 as of the filing data.

What is the aggregate market value of ZWS shares covered in this Form 144?

The notice covers ZWS common stock with an aggregate market value of $1,329,500. This value corresponds to the planned sale of 25,000 shares of common stock to be sold through Goldman Sachs & Co. LLC on the NYSE.

How many ZWS shares are outstanding according to this Form 144?

The issuer reports 165,864,097 shares of ZWS common stock outstanding. This figure provides context for the size of the proposed 25,000-share sale, which represents only a small portion of the total outstanding shares.

When is the proposed sale date for the ZWS shares in this Form 144?

The proposed sale date for the ZWS common stock is August 4, 2026. The shares are to be sold on the NYSE through Goldman Sachs & Co. LLC, as specified in the securities information section of the filing.

What compensation-related ZWS share awards are referenced in the Form 144?

The filing references common stock acquired as compensation through Performance Awards: 5,297 shares dated February 10, 2025 and 19,703 shares dated October 26, 2021. Both awards were granted by the issuer and categorized as compensation.

Which broker is listed for the proposed ZWS stock sale in this Form 144?

The proposed sale of ZWS common stock will be handled by Goldman Sachs & Co. LLC. The broker’s address is given as 200 West Street, New York, NY 10282, and the shares are listed for trading on the NYSE.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	25000	1329500	165864097	08/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2025	Acquired as compensation -- Performance Awards	The Issuer			5297	02/10/2025	Compensation
Common	10/26/2021	Acquired as compensation -- Performance Awards	The Issuer			19703	10/26/2021	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)